Cardlytics Price to Earnings Ratio from 2010 to 2024

CDLX Stock  USD 13.14  0.43  3.17%   
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 16.8 M, as well as many exotic indicators such as Price To Sales Ratio of 1.03, Dividend Yield of 0.21 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
  
This module can also supplement Cardlytics' financial leverage analysis and stock options assessment as well as various Cardlytics Technical models . Check out the analysis of Cardlytics Correlation against competitors.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

About Cardlytics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Cardlytics income statement, its balance sheet, and the statement of cash flows. Cardlytics investors use historical funamental indicators, such as Cardlytics's Price to Earnings Ratio, to determine how well the company is positioned to perform in the future. Although Cardlytics investors may use each financial statement separately, they are all related. The changes in Cardlytics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cardlytics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cardlytics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. It employs 710 people.

Pair Trading with Cardlytics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardlytics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardlytics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cardlytics Stock

  0.66SE Sea Financial Report 21st of May 2024 PairCorr
  0.86WLYB John Wiley SonsPairCorr

Moving against Cardlytics Stock

  0.81Z Zillow Group Class Financial Report 1st of May 2024 PairCorr
  0.81EA Electronic Arts Financial Report 14th of May 2024 PairCorr
  0.77ABTS Abits Group Symbol ChangePairCorr
  0.74IAS Integral Ad Science Financial Report 2nd of May 2024 PairCorr
  0.71CABO Cable One Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Cardlytics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardlytics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardlytics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardlytics to buy it.
The correlation of Cardlytics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardlytics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardlytics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardlytics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cardlytics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardlytics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardlytics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardlytics Stock:
Check out the analysis of Cardlytics Correlation against competitors.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Cardlytics Stock analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.57)
Earnings Share
(3.69)
Revenue Per Share
8.474
Quarterly Revenue Growth
0.081
Return On Assets
(0.06)
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.